HRN-001

N/A

Report date: 2024/07/02 16:38:19
NME

Base Information

Drug NameHRN-001
Drug Alias NameHRN-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionFanconi anaemia complementation group A protein expression stimulants
TargetsFanconi anemia group A protein
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarness Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHarness Therapeutics
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A